The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Engineered T Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Engineered T Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Engineered T Cells market size is estimated to be worth US$ 270.8 million in 2021 and is forecast to a readjusted size of USD 1308.3 million by 2028 with a CAGR of 25.2% during review period. Hospitals accounting for % of the Engineered T Cells global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tumor Infiltrating Lymphocytes segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, and Gilead Sciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Engineered T Cells market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor(CAR)
Market segment by Application, can be divided into
Hospitals
Cancer Research Centers
Clinics
Market segment by players, this report covers
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Engineered T Cells product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Engineered T Cells, with revenue, gross margin and global market share of Engineered T Cells from 2019 to 2022.
Chapter 3, the Engineered T Cells competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Engineered T Cells market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Engineered T Cells research findings and conclusion, appendix and data source.
Geographical Area
Global
The Engineered T Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Engineered T Cells market size is estimated to be worth US$ 270.8 million in 2021 and is forecast to a readjusted size of USD 1308.3 million by 2028 with a CAGR of 25.2% during review period. Hospitals accounting for % of the Engineered T Cells global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tumor Infiltrating Lymphocytes segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Engineered T Cells include Autolus Limited, Bellicum Pharmaceuticals, Cells Medica, Elli Lilly and Company, and Gilead Sciences, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Engineered T Cells market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tumor Infiltrating Lymphocytes
T Cell Receptor {TCR}
Chimeric Antigen Receptor(CAR)
Market segment by Application, can be divided into
Hospitals
Cancer Research Centers
Clinics
Market segment by players, this report covers
Autolus Limited
Bellicum Pharmaceuticals
Cells Medica
Elli Lilly and Company
Gilead Sciences
Juno Therapeutics
Novartis
Oxford Biomedica
Pfizer
Precision Bioscience
Redmile Group
Seeking Alpha
Unum Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Engineered T Cells product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Engineered T Cells, with revenue, gross margin and global market share of Engineered T Cells from 2019 to 2022.
Chapter 3, the Engineered T Cells competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Engineered T Cells market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Engineered T Cells research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Engineered T Cells
1.2 Classification of Engineered T Cells by Type
1.2.1 Overview: Global Engineered T Cells Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Engineered T Cells Revenue Market Share by Type in 2021
1.2.3 Tumor Infiltrating Lymphocytes
1.2.4 T Cell Receptor {TCR}
1.2.5 Chimeric Antigen Receptor(CAR)
1.3 Global Engineered T Cells Market by Application
1.3.1 Overview: Global Engineered T Cells Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Cancer Research Centers
1.3.4 Clinics
1.4 Global Engineered T Cells Market Size & Forecast
1.5 Global Engineered T Cells Market Size and Forecast by Region
1.5.1 Global Engineered T Cells Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Engineered T Cells Market Size by Region, (2017-2022)
1.5.3 North America Engineered T Cells Market Size and Prospect (2017-2028)
1.5.4 Europe Engineered T Cells Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Engineered T Cells Market Size and Prospect (2017-2028)
1.5.6 South America Engineered T Cells Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Engineered T Cells Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Engineered T Cells Market Drivers
1.6.2 Engineered T Cells Market Restraints
1.6.3 Engineered T Cells Trends Analysis
2 Company Profiles
2.1 Autolus Limited
2.1.1 Autolus Limited Details
2.1.2 Autolus Limited Major Business
2.1.3 Autolus Limited Engineered T Cells Product and Solutions
2.1.4 Autolus Limited Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Autolus Limited Recent Developments and Future Plans
2.2 Bellicum Pharmaceuticals
2.2.1 Bellicum Pharmaceuticals Details
2.2.2 Bellicum Pharmaceuticals Major Business
2.2.3 Bellicum Pharmaceuticals Engineered T Cells Product and Solutions
2.2.4 Bellicum Pharmaceuticals Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bellicum Pharmaceuticals Recent Developments and Future Plans
2.3 Cells Medica
2.3.1 Cells Medica Details
2.3.2 Cells Medica Major Business
2.3.3 Cells Medica Engineered T Cells Product and Solutions
2.3.4 Cells Medica Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Cells Medica Recent Developments and Future Plans
2.4 Elli Lilly and Company
2.4.1 Elli Lilly and Company Details
2.4.2 Elli Lilly and Company Major Business
2.4.3 Elli Lilly and Company Engineered T Cells Product and Solutions
2.4.4 Elli Lilly and Company Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Elli Lilly and Company Recent Developments and Future Plans
2.5 Gilead Sciences
2.5.1 Gilead Sciences Details
2.5.2 Gilead Sciences Major Business
2.5.3 Gilead Sciences Engineered T Cells Product and Solutions
2.5.4 Gilead Sciences Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Gilead Sciences Recent Developments and Future Plans
2.6 Juno Therapeutics
2.6.1 Juno Therapeutics Details
2.6.2 Juno Therapeutics Major Business
2.6.3 Juno Therapeutics Engineered T Cells Product and Solutions
2.6.4 Juno Therapeutics Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Juno Therapeutics Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Engineered T Cells Product and Solutions
2.7.4 Novartis Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Oxford Biomedica
2.8.1 Oxford Biomedica Details
2.8.2 Oxford Biomedica Major Business
2.8.3 Oxford Biomedica Engineered T Cells Product and Solutions
2.8.4 Oxford Biomedica Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Oxford Biomedica Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Engineered T Cells Product and Solutions
2.9.4 Pfizer Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Precision Bioscience
2.10.1 Precision Bioscience Details
2.10.2 Precision Bioscience Major Business
2.10.3 Precision Bioscience Engineered T Cells Product and Solutions
2.10.4 Precision Bioscience Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Precision Bioscience Recent Developments and Future Plans
2.11 Redmile Group
2.11.1 Redmile Group Details
2.11.2 Redmile Group Major Business
2.11.3 Redmile Group Engineered T Cells Product and Solutions
2.11.4 Redmile Group Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Redmile Group Recent Developments and Future Plans
2.12 Seeking Alpha
2.12.1 Seeking Alpha Details
2.12.2 Seeking Alpha Major Business
2.12.3 Seeking Alpha Engineered T Cells Product and Solutions
2.12.4 Seeking Alpha Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Seeking Alpha Recent Developments and Future Plans
2.13 Unum Therapeutics
2.13.1 Unum Therapeutics Details
2.13.2 Unum Therapeutics Major Business
2.13.3 Unum Therapeutics Engineered T Cells Product and Solutions
2.13.4 Unum Therapeutics Engineered T Cells Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Unum Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Engineered T Cells Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Engineered T Cells Players Market Share in 2021
3.2.2 Top 10 Engineered T Cells Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Engineered T Cells Players Head Office, Products and Services Provided
3.4 Engineered T Cells Mergers & Acquisitions
3.5 Engineered T Cells New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Engineered T Cells Revenue and Market Share by Type (2017-2022)
4.2 Global Engineered T Cells Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Engineered T Cells Revenue Market Share by Application (2017-2022)
5.2 Global Engineered T Cells Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Engineered T Cells Revenue by Type (2017-2028)
6.2 North America Engineered T Cells Revenue by Application (2017-2028)
6.3 North America Engineered T Cells Market Size by Country
6.3.1 North America Engineered T Cells Revenue by Country (2017-2028)
6.3.2 United States Engineered T Cells Market Size and Forecast (2017-2028)
6.3.3 Canada Engineered T Cells Market Size and Forecast (2017-2028)
6.3.4 Mexico Engineered T Cells Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Engineered T Cells Revenue by Type (2017-2028)
7.2 Europe Engineered T Cells Revenue by Application (2017-2028)
7.3 Europe Engineered T Cells Market Size by Country
7.3.1 Europe Engineered T Cells Revenue by Country (2017-2028)
7.3.2 Germany Engineered T Cells Market Size and Forecast (2017-2028)
7.3.3 France Engineered T Cells Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Engineered T Cells Market Size and Forecast (2017-2028)
7.3.5 Russia Engineered T Cells Market Size and Forecast (2017-2028)
7.3.6 Italy Engineered T Cells Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Engineered T Cells Revenue by Type (2017-2028)
8.2 Asia-Pacific Engineered T Cells Revenue by Application (2017-2028)
8.3 Asia-Pacific Engineered T Cells Market Size by Region
8.3.1 Asia-Pacific Engineered T Cells Revenue by Region (2017-2028)
8.3.2 China Engineered T Cells Market Size and Forecast (2017-2028)
8.3.3 Japan Engineered T Cells Market Size and Forecast (2017-2028)
8.3.4 South Korea Engineered T Cells Market Size and Forecast (2017-2028)
8.3.5 India Engineered T Cells Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Engineered T Cells Market Size and Forecast (2017-2028)
8.3.7 Australia Engineered T Cells Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Engineered T Cells Revenue by Type (2017-2028)
9.2 South America Engineered T Cells Revenue by Application (2017-2028)
9.3 South America Engineered T Cells Market Size by Country
9.3.1 South America Engineered T Cells Revenue by Country (2017-2028)
9.3.2 Brazil Engineered T Cells Market Size and Forecast (2017-2028)
9.3.3 Argentina Engineered T Cells Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Engineered T Cells Revenue by Type (2017-2028)
10.2 Middle East & Africa Engineered T Cells Revenue by Application (2017-2028)
10.3 Middle East & Africa Engineered T Cells Market Size by Country
10.3.1 Middle East & Africa Engineered T Cells Revenue by Country (2017-2028)
10.3.2 Turkey Engineered T Cells Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Engineered T Cells Market Size and Forecast (2017-2028)
10.3.4 UAE Engineered T Cells Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Engineered T Cells Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Engineered T Cells Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Engineered T Cells Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Engineered T Cells Revenue (USD Million) by Region (2017-2022)
Table 5. Global Engineered T Cells Revenue Market Share by Region (2023-2028)
Table 6. Autolus Limited Corporate Information, Head Office, and Major Competitors
Table 7. Autolus Limited Major Business
Table 8. Autolus Limited Engineered T Cells Product and Solutions
Table 9. Autolus Limited Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bellicum Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Bellicum Pharmaceuticals Major Business
Table 12. Bellicum Pharmaceuticals Engineered T Cells Product and Solutions
Table 13. Bellicum Pharmaceuticals Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Cells Medica Corporate Information, Head Office, and Major Competitors
Table 15. Cells Medica Major Business
Table 16. Cells Medica Engineered T Cells Product and Solutions
Table 17. Cells Medica Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Elli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 19. Elli Lilly and Company Major Business
Table 20. Elli Lilly and Company Engineered T Cells Product and Solutions
Table 21. Elli Lilly and Company Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 23. Gilead Sciences Major Business
Table 24. Gilead Sciences Engineered T Cells Product and Solutions
Table 25. Gilead Sciences Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Juno Therapeutics Corporate Information, Head Office, and Major Competitors
Table 27. Juno Therapeutics Major Business
Table 28. Juno Therapeutics Engineered T Cells Product and Solutions
Table 29. Juno Therapeutics Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Engineered T Cells Product and Solutions
Table 33. Novartis Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Oxford Biomedica Corporate Information, Head Office, and Major Competitors
Table 35. Oxford Biomedica Major Business
Table 36. Oxford Biomedica Engineered T Cells Product and Solutions
Table 37. Oxford Biomedica Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Pfizer Corporate Information, Head Office, and Major Competitors
Table 39. Pfizer Major Business
Table 40. Pfizer Engineered T Cells Product and Solutions
Table 41. Pfizer Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Precision Bioscience Corporate Information, Head Office, and Major Competitors
Table 43. Precision Bioscience Major Business
Table 44. Precision Bioscience Engineered T Cells Product and Solutions
Table 45. Precision Bioscience Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Redmile Group Corporate Information, Head Office, and Major Competitors
Table 47. Redmile Group Major Business
Table 48. Redmile Group Engineered T Cells Product and Solutions
Table 49. Redmile Group Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Seeking Alpha Corporate Information, Head Office, and Major Competitors
Table 51. Seeking Alpha Major Business
Table 52. Seeking Alpha Engineered T Cells Product and Solutions
Table 53. Seeking Alpha Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Unum Therapeutics Corporate Information, Head Office, and Major Competitors
Table 55. Unum Therapeutics Major Business
Table 56. Unum Therapeutics Engineered T Cells Product and Solutions
Table 57. Unum Therapeutics Engineered T Cells Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Engineered T Cells Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Engineered T Cells Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Engineered T Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Engineered T Cells Players Head Office, Products and Services Provided
Table 62. Engineered T Cells Mergers & Acquisitions in the Past Five Years
Table 63. Engineered T Cells New Entrants and Expansion Plans
Table 64. Global Engineered T Cells Revenue (USD Million) by Type (2017-2022)
Table 65. Global Engineered T Cells Revenue Share by Type (2017-2022)
Table 66. Global Engineered T Cells Revenue Forecast by Type (2023-2028)
Table 67. Global Engineered T Cells Revenue by Application (2017-2022)
Table 68. Global Engineered T Cells Revenue Forecast by Application (2023-2028)
Table 69. North America Engineered T Cells Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Engineered T Cells Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Engineered T Cells Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Engineered T Cells Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Engineered T Cells Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Engineered T Cells Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Engineered T Cells Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Engineered T Cells Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Engineered T Cells Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Engineered T Cells Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Engineered T Cells Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Engineered T Cells Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Engineered T Cells Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Engineered T Cells Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Engineered T Cells Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Engineered T Cells Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Engineered T Cells Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Engineered T Cells Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Engineered T Cells Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Engineered T Cells Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Engineered T Cells Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Engineered T Cells Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Engineered T Cells Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Engineered T Cells Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Engineered T Cells Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Engineered T Cells Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Engineered T Cells Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Engineered T Cells Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Engineered T Cells Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Engineered T Cells Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Engineered T Cells Picture
Figure 2. Global Engineered T Cells Revenue Market Share by Type in 2021
Figure 3. Tumor Infiltrating Lymphocytes
Figure 4. T Cell Receptor {TCR}
Figure 5. Chimeric Antigen Receptor(CAR)
Figure 6. Engineered T Cells Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Cancer Research Centers Picture
Figure 9. Clinics Picture
Figure 10. Global Engineered T Cells Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Engineered T Cells Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Engineered T Cells Revenue Market Share by Region (2017-2028)
Figure 13. Global Engineered T Cells Revenue Market Share by Region in 2021
Figure 14. North America Engineered T Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Engineered T Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Engineered T Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Engineered T Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Engineered T Cells Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Engineered T Cells Market Drivers
Figure 20. Engineered T Cells Market Restraints
Figure 21. Engineered T Cells Market Trends
Figure 22. Autolus Limited Recent Developments and Future Plans
Figure 23. Bellicum Pharmaceuticals Recent Developments and Future Plans
Figure 24. Cells Medica Recent Developments and Future Plans
Figure 25. Elli Lilly and Company Recent Developments and Future Plans
Figure 26. Gilead Sciences Recent Developments and Future Plans
Figure 27. Juno Therapeutics Recent Developments and Future Plans
Figure 28. Novartis Recent Developments and Future Plans
Figure 29. Oxford Biomedica Recent Developments and Future Plans
Figure 30. Pfizer Recent Developments and Future Plans
Figure 31. Precision Bioscience Recent Developments and Future Plans
Figure 32. Redmile Group Recent Developments and Future Plans
Figure 33. Seeking Alpha Recent Developments and Future Plans
Figure 34. Unum Therapeutics Recent Developments and Future Plans
Figure 35. Global Engineered T Cells Revenue Share by Players in 2021
Figure 36. Engineered T Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Engineered T Cells Revenue Market Share in 2021
Figure 38. Global Top 10 Players Engineered T Cells Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Engineered T Cells Revenue Share by Type in 2021
Figure 41. Global Engineered T Cells Market Share Forecast by Type (2023-2028)
Figure 42. Global Engineered T Cells Revenue Share by Application in 2021
Figure 43. Global Engineered T Cells Market Share Forecast by Application (2023-2028)
Figure 44. North America Engineered T Cells Sales Market Share by Type (2017-2028)
Figure 45. North America Engineered T Cells Sales Market Share by Application (2017-2028)
Figure 46. North America Engineered T Cells Revenue Market Share by Country (2017-2028)
Figure 47. United States Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Engineered T Cells Sales Market Share by Type (2017-2028)
Figure 51. Europe Engineered T Cells Sales Market Share by Application (2017-2028)
Figure 52. Europe Engineered T Cells Revenue Market Share by Country (2017-2028)
Figure 53. Germany Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Engineered T Cells Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Engineered T Cells Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Engineered T Cells Revenue Market Share by Region (2017-2028)
Figure 61. China Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Engineered T Cells Sales Market Share by Type (2017-2028)
Figure 68. South America Engineered T Cells Sales Market Share by Application (2017-2028)
Figure 69. South America Engineered T Cells Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Engineered T Cells Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Engineered T Cells Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Engineered T Cells Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Engineered T Cells Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
